The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases.
|Journal||Technical Innovations and Patient Support in Radiation Oncology|
|Publication status||Published - Jun 2022|
Bibliographical notePublisher Copyright:
© 2022 The Author(s)
- (3–6): oligometastases
- MR-guided radiotherapy